Cargando…
Synaptic alterations as a common phase in neurological and neurodevelopmental diseases: JNK is a key mediator in synaptic changes
Autores principales: | Musi, Clara Alice, Bonadonna, Carlo, Borsello, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727415/ https://www.ncbi.nlm.nih.gov/pubmed/36018163 http://dx.doi.org/10.4103/1673-5374.346488 |
Ejemplares similares
-
JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
por: Musi, Clara Alice, et al.
Publicado: (2020) -
JNK Activation Correlates with Cognitive Impairment and Alteration of the Post-Synaptic Element in the 5xFAD AD Mouse Model
por: Priori, Erica Cecilia, et al.
Publicado: (2023) -
Colocalization and Interaction Study of Neuronal JNK3, JIP1, and β-Arrestin2 Together with PSD95
por: Musi, Clara Alice, et al.
Publicado: (2022) -
Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders
por: Ali Rodriguez, Rachel, et al.
Publicado: (2018) -
Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence
por: Fessel, Jeffrey
Publicado: (2021)